Berkeley Lights IPO Presentation Deck slide image

Berkeley Lights IPO Presentation Deck

Growing workflow offering with a high degree of R&D leverage High degree of leverage across markets, applications and customers Workflows in development Opto Viral Neutralization 1.0 Opto Cell Therapy Development 2.0 Opto Cell Therapy Manufacturing Opto Cell Therapy Patient Monitoring Opto SynBio Discovery 1.0 Opto SynBio Development 1.0 IGT Antibody therapeutics Cell therapy Synthetic biology 6 2015 2016 As of April 30, 2020 2 Planned 2018 6 commercial workflows¹ Opto Cell Therapy Development 1.0 Opto Plasma B Discovery 3.0 Opto Cell Line Development 2.0 Opto Cell Line Development 1.0 2017 2019 2020 Opto Plasma B Discovery 2.0 Opto Plasma B Discovery 1.0 Developing a new workflow is a function of adding new single cell assays, changing one or more of the four modules or cell types Our 6 commercial workflows, incorporate 16 assays and over 11 cell classes 22
View entire presentation